Advanced Filter

Filter by Group

Filter by Market Availability

Displaying 1 drug
Ertugliflozin is a sodium-dependent glucose cotransporter-2 (SGLT2) inhibitor used to treat type II diabetes mellitus. It works to block glucose reabsorption from the glomerulus. Ertugliflozin was first approved by the FDA in December 2017.[A261951, L1132] It was also approved by the European Commission in March 2018.
Approved
Investigational
Matched Synonyms: … Ertugliflozin
Matched Name: … Ertugliflozin
Matched Description: … [A31581] Ertugliflozin was first approved by the FDA in December 2017. ... Ertugliflozin is a sodium-dependent glucose cotransporter-2 (SGLT2) inhibitor used to treat type II diabetes …
Matched Mixtures name: … Steglujan (Ertugliflozin 5mg/Sitagliptin 100mg) Film-Coated Tablets ... Steglujan (Ertugliflozin 15mg/Sitagliptin 100mg) Film-Coated Tablets ... Segluromet (Ertugliflozin 2.5mg/ Metformin 500mg) Film-Coated Tablet …
Matched Salts name: … Ertugliflozin pidolate
Matched Categories: … sitagliptin and ertugliflozin ... metformin and ertugliflozin ... ertugliflozin ... Alimentary Tract and Metabolism …
Displaying 1 drug